DLO:NASDAQDLocal Limited Analysis
Data as of 2026-03-29 - not real-time
$12.27
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
DLocal’s share price of $12.27 sits below its 20‑day (12.05), 50‑day (12.77) and 200‑day (13.12) moving averages, signaling a short‑term bearish bias. Yet the MACD histogram has turned positive, volume is increasing, and the RSI hovers around 49, hinting at a possible near‑term reversal. The stock trades at a trailing P/E of 18.9 and forward P/E of 11.3—well under the industry average of 32—while a discounted cash‑flow model estimates a fair value of $43.6, implying roughly 44% upside. Revenue surged 65% YoY to $1.09 bn, TPV jumped 70% YoY, and operating margins sit near 19%, reflecting high growth. A strong balance sheet ($843 m cash vs $90 m debt) and a 0% payout ratio sustain the 1.58% dividend, making the payout sustainable. The market cap of $3.6 bn and an average 10‑day volume of 2.2 m shares provide decent liquidity. The beta of 1.23 suggests the stock moves more than the market, amplifying both upside and downside.
Nevertheless, volatility is elevated at 56% over the past 30 days and beta of 1.23 indicate pronounced price swings, while exposure to emerging‑market regulators raises medium‑high geographic and regulatory risk. The company’s ROE of 37% and a track record of beating earnings estimates have spurred bullish commentary and a recent 9% rally to $12.53. The current support at $11.16 and resistance near $13.5 give a clear technical range for traders. While the max drawdown of 28% over recent periods underscores downside risk, the upside potential remains compelling. Overall sentiment on the Fear & Greed Index is in "Greed" territory (65.98), reflecting bullish market mood toward the stock.
Nevertheless, volatility is elevated at 56% over the past 30 days and beta of 1.23 indicate pronounced price swings, while exposure to emerging‑market regulators raises medium‑high geographic and regulatory risk. The company’s ROE of 37% and a track record of beating earnings estimates have spurred bullish commentary and a recent 9% rally to $12.53. The current support at $11.16 and resistance near $13.5 give a clear technical range for traders. While the max drawdown of 28% over recent periods underscores downside risk, the upside potential remains compelling. Overall sentiment on the Fear & Greed Index is in "Greed" territory (65.98), reflecting bullish market mood toward the stock.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Positive MACD histogram and rising volume
- Technical support at $11.16 offering downside cushion
- Valuation discount to DCF fair value
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 65% YoY revenue growth
- Strong cash generation and low debt
- Forward P/E of 11.3 indicating cheapness
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustained high ROE (37%)
- Expanding TPV in emerging markets
- Robust balance sheet with ample cash
Key Metrics & Analysis
Financial Health
Revenue Growth65.20%
Profit Margin18.00%
P/E Ratio18.9
ROE37.21%
ROA10.13%
Debt/Equity15.86
P/B Ratio6.4
Op. Cash Flow$415.5M
Free Cash Flow$332.3M
Industry P/E32.0
Technical Analysis
TrendBearish
RSI49.0
Support$11.16
Resistance$13.50
MA 20$12.05
MA 50$12.77
MA 200$13.12
MACDBullish
VolumeIncreasing
Fear & Greed Index65.98
Valuation
Fair Value$43.58
Target Price$17.75
Upside/Downside44.66%
GradeUndervalued
TypeGrowth
Dividend Yield1.58%
Risk Assessment
Beta1.24
Volatility56.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.